Inhibition of tumor growth in vitro and in vivo by fucoxanthin against melanoma B16F10 cells

Environmental Toxicology and Pharmacology

Volumn 35, Issue 1, 2013, Pages 39-46

  Kim, Kil Nam ^a   Ahn, Ginnae ^b   Heo, Soo Jin ^c   Kang, Sung Myung ^d   Kang, Min Cheol ^d   Yang, Hye Mi ^a   Kim, Daekyung ^a   Roh, Seong Woon ^a   Kim, Se Kwon ^e   Jeon, Byong Tae ^f   Park, Pyo Jam ^g   Jung, Won Kyo ^h   Jeon, You Jin ^b  

^a Korea Basic Science Institute (KBSI)   (South Korea)

^b TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^c Korea Research Institute of Ships and Ocean Engineering   (South Korea)

^d Jeju National University   (South Korea)

^e Pukyong National University   (South Korea)

^f Konkuk University School of Medicine   (South Korea)

^g Konkuk University   (South Korea)

^h Chosun University   (South Korea)

Author keywords

Apoptosis; Bcl xL; Cell arrest; Fucoxanthin; Melanoma cell lines (B16F10 cells); P27Kip1

Indexed keywords

CASPASE 3; CASPASE 9; CYCLIN D1; CYCLIN D2; CYCLIN DEPENDENT KINASE 4; FUCOXANTHIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER SIZE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CONTROLLED STUDY; DRUG CYTOTOXICITY; ENZYME ACTIVATION; IN VITRO STUDY; IN VIVO STUDY; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; TUMOR BURDEN; XANTHOPHYLLS;

INTRACISTERNAL A-PARTICLES; MUS;

EID: 84870809834     PISSN: 13826689     EISSN: 18727077     Source Type: Journal    
DOI: 10.1016/j.etap.2012.10.002     Document Type: Article

References (49)

1. Adams J.M., Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998, 281:1322-1326.
2. Albino A.P., Juan G., Traganos F., Reinhart L., Connolly J., Rose D.R., Darzynkiewicz Z. Cell cycle arrest and apoptosis of melanoma cells by docosahexaenoic acid: association with decreased pRb phosphorylation. Cancer Res. 2000, 60:4139-4145.
3. Amiri K.I., Horton L.W., LaFleur B.J., Sosman L.A., Richmond A. Augmenting chemosensitivity of malignant melanoma tumors via proteasome inhibition: implication for bortezomib (VELCADE, PS- 341) as a therapeutic agent for malignant melanoma. Cancer Res. 2004, 64:4912-4918.
4. Antonsson B., Martinou J.C. The Bcl-2 protein family. Exp. Cell Res. 2000, 256:50-57.
5. Bai F., Pei X.H., Godfrey V.L., Xiong Y. Haploinsufficiency of p18 (INK4c) sensitizes mice to carcinogen-induced tumorigenesis. Mol. Cell. Biol. 2003, 23:1269-1277.
6. Bold R.J., Termuhlen P.M., McConkey D.J. Apoptosis, cancer and cancer therapy. Surg. Oncol. 1997, 6:133-142.
7. Budihardjo I., Oliver H., Lutter M., Luo X., Wang X. Biochemical pathways of caspase activation during apoptosis. Annu. Rev. Cell Dev. Biol. 1999, 15:269-290.
8. Das S.K., Hashimoto T., Kanazawa K. Growth inhibition of human hepatic carcinoma HepG2 cells by fucoxanthin is associated with down-regulation of cyclin D. Biochim. Biophys. Acta 2008, 1780:743-749.
9. Deveraux Q.L., Reed J.C. IAP family proteins: suppressors of apoptosis. Genes Dev. 1999, 13:239-252.
10. Ferlay J., Bray F., Pisani P., Parkin D.M. GLOBOCAN 2002. Cancer Incidence, Mortality and Prevalence Worldwide. IARC Cancer Base No. 5 Version 2.0 2004, IARC Press, Lyon, France.
11. Gray-Schopfer V.C., Karasarides M., Hayward R., Marais R. Tumor necrosis factor-alpha blocks apoptosis in melanoma cells when BRAF signaling is inhibited. Cancer Res. 2007, 67:122-129.
12. Green D.R., Reed J.C. Mitochondria and apoptosis. Science 1998, 281:1309-1312.
13. Gschwind M., Huber G. Apoptotic cell death induced by β-amyloid 1-42 peptide is cell type dependent. J. Neurochem. 1995, 65:292-300.
14. Hacker E., Muller H.K., Irwin N., Gabrielli B., Lincoln D., Pavey S., Powell M.B., Malumbres M., Barbacid M., Hayward N., Walker G. Spontaneous and UV radiation-induced multiple metastatic melanomas in Cdk4R24C/R24C/TPras mice. Cancer Res. 2006, 66:2946-2952.
15. Ham Y.M., Yoon W.J., Park S.Y., Jung Y.H., Kim D.K., Jeon Y.J., Wijesinghe W.A.J.P., Kang S.M., Kim K.N. Inviestigation of the component of Lycopodium serratum extract that inhibits proliferation and mediates apoptosis of human HL-60 leukemia cells. Food Chem. Toxicol. 2012, 50:2629-2634.
16. Harper J.W., Elledge S.J. Cdk inhibitors in development and cancer. Curr. Opin. Genet. Dev. 1996, 6:56-64.
17. Hengartner M.O. The biochemistry of apoptosis. Nature 2000, 407:770-776.
18. Hockenbery D.M., Oltvai Z.N., Yin X.M., Milliman C.L., Korsmeyer S.J. Bcl-2 function in an antioxidant pathway to prevent apoptosis. Cell 1993, 75:241-251.
19. Hsiao Y.C., Hsieh Y.S., Kuo W.H., Chiou H.L., Yang S.F., Chiang W.L., Chu S.C. The tumor-growth inhibitory activity of flavanone and 2'-OH flavanone in vitro and in vivo through induction of cell cycle arrest and suppression of cyclins and CDKs. J. Biomed. Sci. 2007, 14:107-119.
20. Hu W., Kavanagh J.J. Anticancer therapy targeting the apoptotic pathway. Lancet Oncol. 2003, 4:721-729.
21. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., Thun M. Cancer statistics. CA Cancer J. Clin. 2008, 58:71-96.
22. Jiang W., Mikochik P.J., Ra J.H., Lei H., Flaherty K.T., Winkler J.D., Spitz F.R. HIV protease inhibitor nelfinavir inhibits growth of human melanoma cells by induction of cell cycle arrest. Cancer Res. 2007, 67:1221-1227.
23. Kaina B. DNA damage-triggered apoptosis: critical role of DNA repair, double-strand breaks, cell proliferation and signaling. Biochem. Pharmacol. 2003, 66:1547-1554.
24. Kaufmann S., Hengartner M.O. Programmed cell death: alive and well in the new millennium. Trends Genet. 2001, 11:526-534.
25. Kim K.N., Ham Y.M., Moon J.Y., Kim M.J., Jung Y.H., Jeon Y.J., Lee N.H., Kang N., Yang H.M., Kim D., Hyun C.G. Acanthoic acid induces cell apoptosis through activation of the p38 MAPK pathway in HL-60 human promyelocytic leukaemia. Food Chem. 2012, 135:2112-2117.
26. Kim K.N., Heo S.J., Kang S.M., Ahn G., Jeon Y.J. Fucoxanthin induces apoptosis in human leukemia HL-60 cells through a ROS-mediated Bcl-xL pathway. Toxicol. In Vitro 2010, 24:1648-1654.
27. Kim K.N., Heo S.J., Yoon W.J., Kang S.M., Ahn G., Yi T.H., Jeon Y.J. Fucoxanthin inhibits the inflammatory response by suppressing the activation of NF-κB and MAPKs in lipopolysaccharide-induced RAW 264.7 marcophages. Eur. J. Pharmacol. 2010, 649:369-375.
28. Konopleva M., Zhao S., Xie Z., Segall H., Younes A., Claxton D.F., Estrov Z., Kornblau S.M., Andreeff M. Apoptosis: molecules and mechanisms. Adv. Exp. Med. Biol. 1999, 457:217-236.
29. Korsmeyer S.J. Bcl-2 gene family and the regulation of programmed cell death. Cancer Res. 1999, 59:1693-1700.
30. Lizard G., Fournel S., Genestier L., Dhedin N., Chaput C., Flacher M., Mutin M., Panaye G., Revillard J.P. Kinetics of plasma membrane and mitochondrial alterations in the cells undergoing apoptosis. Cytometry 1995, 21:275-283.
31. Lloyd R.V., Erickson L.A., Jin L., Kulig E., Qian X., Cheville J.C., Scheithauer B.W. p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am. J. Pathol. 1999, 154:313-323.
32. Morgan D.O. Principles of CDK regulation. Nature 1995, 374:131-134.
33. Nakanishi M., Shimada M., Niida H. Genetic instability in cancer cells by impaired cell cycle checkpoints. Cancer Sci. 2006, 97:984-989.
34. Nakazawa Y., Sashima T., Hosokawa M., Miyashita K. Comparative evaluation of growth inhibitory effect of stereoisomers of fucoxanthin in human cancer cell lines. J. Funct. Foods 2009, 1:88-97.
35. Nicoletti I., Migliorati G., Pagliacci M.C., Grignani F., Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 1991, 139:271-279.
36. Oliver F.J., Rubia G., Rolli V., Ruiz-Ruiz M.C., Murcia G., Murcia J.M. Importance of poly (ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant. J. Biol. Chem. 1998, 273:33533-33539.
37. Pei X.H., Xiong Y. Biochemical and cellular mechanisms of mammalian CDK inhibitors: a few unresolved issues. Oncogene 2005, 24:2787-2795.
38. Puri P.L., MacLachlan T.K., Levrero M., Giordano A. The intrinsic cell cycle: from yeast to mammals. The Molecular Basis of Cell Cycle and Growth Control 1999, 15-79. Wiley-Liss, New York. G.S. Stein, R. Baserga, A. Giordano, D.T. Denhardt (Eds.).
39. Roy S., Kaur M., Agarwal C., Tecklenburg M., Sclafani R.A., Agarwal R. p21 and p27 induction by silibinin is essential for its cell cycle arrest effect in prostate carcinoma cells. Mol. Cancer Ther. 2007, 6:2696-2707.
40. 1 cell cycle arrest and gadd45 expression by the carotenoid fucoxanthin in human cancer cells. Biochim. Biophys. Acta 2009, 1790:260-266.
41. 1 cyclins. Cell 1993, 73:1059-1065.
42. 1 phase progression: cycling on cue. Cell 1994, 79:551-555.
43. 1 cyclin-dependent kinases. Genes Dev. 1995, 9:1149-1163.
44. Steller H. Mechanisms and genes of cellular suicide. Science 1995, 267:1445-1449.
45. 2/M cell cycle checkpoint. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:3706-3711.
46. Weinberg R.A. The retinoblastoma protein and cell cycle control. Cell 1995, 81:323-330.
47. Weinstein I.B. Disorders in cell circuitry during multistage carcinogenesis: the role of homeostasis. Carcinogenesis 2000, 21:857-864.
48. 2+ productions and caspase-3 activation. Mutat. Res. 2006, 601:71-82.
49. Yu R.X., Hu X.M., Xu S.Q., Jiang Z.J., Yang W. Effects of fucoxanthin on proliferation and apoptosis in human gastric adenocarcinoma MGC-803 cells via JAK/STAT signal pathway. Eur. J. Pharmacol. 2011, 657:10-19.